Balance Capital Partners L.P.
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 14, 2026), Balance Capital Partners L.P. reported 10 stock positions worth $139.3 million. Its top holding was Perimeter Solutions (PRM) at 70.0% of the portfolio, followed by SS SPDR S&P Biotech ETF (XBI, 7.3%) and Resolute Holdings Manag (RHLD, 6.7%). Compared with Q1 2026, it opened 7 new positions, sold out of 3 and added to 1. The biggest buy was a new position in SS SPDR S&P Biotech ETF (XBI) and the biggest sale an exit from Stevanato Group SPA (STVN).
- Most Recent 13F
- Q2 2026
- Location
- MIAMI, FL
- CIK
- 0002109256
- Portfolio Value
- $139.3M (Q2 2026)
- SEC Filing
- 0001892688-26-000125 ↗ filed Aug 14, 2026
Holdings Value
Holdings 10 stocks · $139.3M
| PRM Perimeter Solutions Inc. | 70.00% | 2,735,521 | $97.5M | No change |
| XBI SS SPDR S&P Biotech ETF | 7.27% | 64,000 | $10.1M | New |
| RHLD Resolute Holdings Manag | 6.69% | 64,526 | $9.3M | No change |
| TSM Taiwan Semiconductor-SP ADR | 3.77% | 11,000 | $5.3M | New |
| BLTE Belite Bio Inc. - ADR | 2.49% | 22,500 | $3.5M | Add +55.2% |
| CPNG Coupang Inc. | 2.45% | 196,897 | $3.4M | New |
| SN Sharkninja Inc. | 2.24% | 20,504 | $3.1M | New |
| MRVL Marvell Technology Inc. | 1.92% | 9,000 | $2.7M | New |
| TTMI TTM Technologies | 1.75% | 13,000 | $2.4M | New |
| DNA Ginkgo Bioworks Holdings Inc. | 1.42% | 199,009 | $2.0M | New |
Portfolio Sells Q1 2026 → Q2 2026
Portfolio Buys Q1 2026 → Q2 2026
| XBI SS SPDR S&P Biotech ETF | New | 7.27% | +7.27 |
| TSM Taiwan Semiconductor-SP ADR | New | 3.77% | +3.77 |
| CPNG Coupang Inc. | New | 2.45% | +2.45 |
| SN Sharkninja Inc. | New | 2.24% | +2.24 |
| MRVL Marvell Technology Inc. | New | 1.92% | +1.92 |
| TTMI TTM Technologies | New | 1.75% | +1.75 |
| DNA Ginkgo Bioworks Holdings Inc. | New | 1.42% | +1.42 |
| BLTE Belite Bio Inc. - ADR | Add +55.2% | 2.49% | −0.14 |